01-05-2024
30-04-2024
26-04-2024
Wimbledon, the only Grand Slam still played on grass, is intent on becoming genuinely green. Organisers of the event have set ambitious, clear goals on how to achieve that. Their game plan is all about taking a high level view.
Europeans suffer 100,000 amputations a year because of the escalating issue of ‘diabetic foot’. Diabetes already burdens health systems, but without more frequent monitoring programmes, experts warn the amputation crisis will get worse.
Poland's pharmaceutical industry says there's still a long journey ahead for the revision of the EU's pharma legislation. Despite the Pharma Package now heading to Council, the Polish Ministry of Health chooses to remain silent.
Slovakia's much-needed hospital reforms aim to create an optimised network of categorised hospitals in Slovakia, ensuring higher quality of provided health care for patients. However, the system is plagued by delays and controversies.
The Bulgarian parliament has adopted a decision requiring the state to pay for the treatment of some patients with rare diseases. The decision follows decades of legal battles and accusations of discrimination.
The Hungarian pharmaceutical market could be fundamentally reorganised following a government decree entrusting the supply of hospital medicines to a 'project company' with special rights. The change will take effect in January. Stakeholders are alarmed.
The first National Strategy on Quality of Care, Patient Safety, and Patient Experience is being developed in Greece. It aims to build, strengthen, and consolidate the quality of care through national policies.
A new antibiotic against gram-negative bacteria hasn’t been developed since the 1970s. Now, a European research team led by Swedish scientists has discovered multi-drug-resistant bug-killing compounds that could lead to a new class of antibiotics.
Each day, 21 people die while awaiting a transplant in Europe. With the European Parliament Elections approaching, the European Society for Organ Transplantation presents an actionable roadmap for fair and sustainable transformations in the field over the next five years.
A Belgian court will hold a hearing on 17 May where it will be decided whether Belgian or EU prosecutors are competent to continue the 'Pfizergate' probe involving European Commission boss Ursula von der Leyen, according to a document seen by Euractiv.
The European Parliament adopted new rules for use of blood, tissues and other substances of human origin (24 April). The so-called SoHO regulation (substances of human origin), is an important update of directives that are more than 20 years old. The focus is on safety and security of supply.
Europe’s Critical Medicines Alliance launches today. This is an occasion to reflect on the policy measures that can further enhance access to critical medicines across the EU.
On Wednesday (24 April), members of the European Parliament definitively adopted the EU directive on tackling violence against women, after two years of intense negotiations with the member states.
The European Parliament adopted on Wednesday (24 April) the European Health Data Space Regulation, a key step for Europe's digital healthcare that should facilitate access to cross-border medical data, by 445 votes in favour and 142 against.
With many EU states grappling with medicine shortages, health ministers finally have their first chance to discuss the Commission’s proposal, for a Critical Medicines Alliance face-to-face in Brussels today (24 April), on the second day of the informal Health Council.
The European Commission announced on Wednesday (24 April) it has opened an investigation into Chinese discrimination against European companies in the public procurement market for medical devices.
As member states prepare to ramp up the building renovation rate, there is an unprecedented opportunity to hardwire health aspects into the built environment. The brand-new edition of the Healthy Buildings Barometer maps why and how health, energy and climate …
As EU health ministers gather in Brussels on 23-24 April to discuss access to critical medicines and formally launch the Critical Medicines Alliance, the European Medicines Agency (EMA) has published its own recommendations to address vulnerabilities in the production and delivery of medicines on the EU’s critical list.
Poland's clinical trials give access to innovative therapies for over 25,000 patients, but a new Medical Research Agency survey reports half of Poles lack any real understanding of clinical trials, hindering long-term success.
A new analysis by Ernst & Young (EY) for the Czech Association of Innovative Pharmaceutical Industry (AIFP) underscores the benefits of centre-based medical care in Czechia. However, rising costs are fast straining the business model.
Bulgaria remains the only country in the EU where the death rate from oncological diseases continues to rise. Patients face financial and organisational difficulties in accessing treatment, even though public funding has more than doubled in the past five years.
The Belgian Presidency is gearing up to tackle the escalating issue of medicine shortages across Europe. Experts call for enhanced collaboration, solidarity, and transparency to combat this crisis effectively.
The Netherlands has been confronted with a new report showing inequalities in cancer screening between people with high and low incomes. Advocates are calling for public health to be embedded in all types of policies to reduce treatment disparities.
In the last two decades in Europe, extreme heat-related mortality has increased by around 30%, according to a joint report by the EU's Copernicus Climate Change Service (C3S) and the UN's World Meteorological Organisation (WMO) published on Tuesday (22 April).
